ORIC Pharmaceuticals, Inc. (ORIC) Financials

NASDAQ Currency in USD Disclaimer

$8.19

south_east -$0.14 (-1.68%)
Day's range
$8
Day's range
$8.43

ORIC Income statement / Annual

Last year (2023), ORIC Pharmaceuticals, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, ORIC Pharmaceuticals, Inc.'s net income was -$100.70 M. See ORIC Pharmaceuticals, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $1.03 M $966,000.00 $897,000.00 $970,000.00 $1.00 M $900,000.00 $900,000.00
Gross Profit -$1.03 M -$966,000.00 -$897,000.00 -$970,000.00 -$1.00 M -$900,000.00 -$900,000.00
Gross Profit Ratio 0 0 0 0 0 0 0
Research and Development Expenses $85.17 M $61.68 M $56.86 M $35.92 M $22.84 M $19.03 M $19.13 M
General & Administrative Expenses $25.61 M $25.09 M $22.01 M $13.42 M $5.73 M $3.35 M $3.42 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$900,000.00
Selling, General & Administrative Expenses $25.61 M $25.09 M $22.01 M $13.42 M $5.73 M $3.35 M $2.52 M
Other Expenses $0.00 $5.00 M $15,000.00 $177,000.00 $289,000.00 $233,000.00 $0.00
Operating Expenses $110.78 M $86.77 M $78.87 M $49.34 M $28.57 M $22.37 M $21.64 M
Cost And Expenses $110.78 M $86.77 M $78.87 M $49.34 M $28.57 M $22.37 M $22.54 M
Interest Income $10.08 M $2.65 M $141,000.00 $306,000.00 $1.40 M $775,000.00 $251,000.00
Interest Expense $0.00 $2.65 M $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $1.03 M $966,000.00 $897,000.00 $970,000.00 $1.00 M $900,000.00 $900,000.00
EBITDA -$109.75 M -$91.77 M -$77.97 M -$74.19 M -$27.54 M -$20.46 M -$21.13 M
EBITDA Ratio 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0
Total Other Income/Expenses Net $10.08 M $2.65 M $156,000.00 $483,000.00 $1.69 M $1.01 M $512,000.00
Income Before Tax -$100.70 M -$89.12 M -$78.72 M -$73.70 M -$26.88 M -$21.36 M -$22.03 M
Income Before Tax Ratio 0 0 0 0 0 0 0
Income Tax Expense $0.00 $2.36 M -$1.04 M $23.57 M -$1.40 M -$1.01 M $0.00
Net Income -$100.70 M -$91.48 M -$77.68 M -$97.27 M -$25.49 M -$21.36 M -$22.03 M
Net Income Ratio 0 0 0 0 0 0 0
EPS -1.96 -2.31 -2.05 -4.43 -0.85 -1.12 -0.74
EPS Diluted -1.96 -2.31 -2.05 -4.43 -0.85 -1.12 -0.74
Weighted Average Shares Out $51.45 M $39.66 M $37.95 M $21.94 M $29.90 M $19.14 M $29.90 M
Weighted Average Shares Out Diluted $51.45 M $39.66 M $37.95 M $21.94 M $29.90 M $19.14 M $29.90 M
Link